Peer-influenced content. Sources you trust. No registration required. This is HCN.

The Epoch TimesFDA Notice: Blood Pressure Drugs Recalled After Powerful Opioid Found

Synthetic Opioid Oxycodone Found in Blood Pressure Drugs

In an alarming revelation, a blood pressure medication has been recalled due to contamination with the synthetic opioid oxycodone. The U.S. Food and Drug Administration (FDA) has published a notice regarding this serious issue.

HCN Medical Memo
This incident underscores the critical importance of stringent quality control measures in pharmaceutical manufacturing. As healthcare professionals, it is crucial to stay updated on such recalls to ensure patient safety and effective treatment outcomes. This particular recall serves as a reminder of the potential risks associated with medication contamination and the importance of monitoring patients’ responses to their medications.

Key Points

  • The FDA has published a notice regarding a recall of a blood pressure medication.
  • The manufacturer, KVK-Tech, Inc., initiated the recall.
  • The medication in question is 10 mg betaxolol tablets.
  • The recall was triggered by the discovery of a 5 mg oxycodone HCl tablet on the packaging line.
  • The specific lot being recalled is Batch Number 17853A1.
  • Betaxolol is a type of beta blocker that can dilate your blood vessels and slow your heart rate, allowing your blood pressure to drop.
  • More than 1,321 recalls were issued last year for human drug products that were defective or violated laws enforced by the FDA.

“Quality is never an accident; it is always the result of high intention, sincere effort, intelligent direction and skillful execution; it represents the wise choice of many alternatives.” – William A. Foster

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form